|
DOX
|
Glioblastoma multiforme
|
1.04 μm
|
Lipid-based
|
Evaluating the efficacy of BBB opening and medication transportation
|
[229]
|
|
DOX
|
Malignant glioma
|
4.00 μm
|
Lipid-based
|
The suppression rate of human glioblastoma cells is being investigated
|
[230]
|
|
DOX
|
Pancreas carcinoma
|
1.02 μm
|
Lipid-based
|
Pancreatic cancer treatment using a rat model
|
[229]
|
|
DOX
|
Liver tumor
|
1.50 μm
|
Poly(lactic acid)-based
|
Treating liver tumors in a rabbit model
|
[231]
|
|
DOX
|
Breast cancer
|
1.64 μm
|
Lipid-based
|
Examining the anticancer activity in human breast cancer cells
|
[232]
|
|
Paclitaxel (PTX)
|
Ovarian cancer
|
1.80 μm
|
Lipid-based
|
Treatment of ovarian cancer in a mouse model
|
[233]
|
|
PTX
|
Ovarian cancer
|
1.80 μm
|
Lipid-based
|
Evaluating the anticancer activity for ovarian carcinoma cells in human
|
[234]
|
|
PTX
|
Breast cancer
|
1.68 μm
|
Lipid-based
|
Breast cancer treatment efficacy in a mice model
|
[235]
|
|
Docetaxel
|
Colon adenocarcinoma
|
3.30 μm
|
Lipid-based
|
Researching the anticancer function on human colon adenocarcinoma cell line
|
[236]
|
|
Hydroxycamptothecin
|
Liver tumor
|
1.48 μm
|
Lipid-based
|
Accelerating the inhibitory rate of tumor
|
[237]
|
|
Carmustine
|
Glioblastoma multiforme
|
1.32 μm
|
Lipid-based
|
Assessing the glioma therapeutic effectiveness in a rat model
|
[229]
|
